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ABSTRACT 
The aim of this study was to evaluate the long-term safety and efficacy of photorefractive keratectomy (PRK) for patients with 
myopia and thin corneas. In this retrospective case series, we included 74 eyes of 38 patients with myopia and central corneal 
thickness (CCT) < 550 µm who underwent PRK and had a mean postoperative follow-up period of four years. The following factors 
were evaluated: CCT, refraction, uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), ablation depth, safety and 
efficacy indices (i.e., the ratio of the mean postoperative BCVA to the mean preoperative BCVA, and the ratio of the mean 
postoperative UCVA to mean preoperative the BCVA, respectively), and evidence of corneal ectasia (based on Orbscan topography 
images).The patients were aged 20 – 46 years (mean ±SD age, 28.18± 6.82 years). The mean ± SD pre- and postoperative 
CCTwas485.92 ± 9.27 µm and 434.84 ± 20.48 µm, respectively. The mean ± SD pre- and postoperative myopia was -2.77 D ± 1.51 
and -0.24 ± 0.39 D, respectively, and the mean ± SD pre- and postoperative astigmatism was -0.82 D ± 0.99 and -0.37 ± 0.37 D, 
respectively. The mean pre- and postoperative BCVA and postoperative UCVA was 0.011 ± 0.03 Logarithm of the Minimum Angle of 
Resolution (log MAR), 0.003 ± 0.01 log MAR, and 0.054 ± 0.09 log MAR, respectively. The mean ± SD ablation depth, safety index 
and efficacy index was 54.34 ± 16.28 µm, 0.02 ± 0.12, and 0.11 ± 0.50, respectively. Regarding the postoperative corneal clarity, 72 
eyes (97.3%) had a clear cornea (grade 0) and the remaining two eyes of one patient (2.70%) had a trace haze (grade 1). There was 
no evidence of corneal ectasia on any of the Orbscan topography images. Thus, among patients with myopia and thin corneas (<500 
µm), PRK seems to be acceptable in terms of both safety and efficacy 4 years after surgery, based on the stability of postoperative 
refraction, visual acuity, and topographic outcomes, and outcomes based on the safety and efficacy indexes. 
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Introduction 
Central corneal thickness (CCT) is an important 
preoperative factor that should be measured before 
conducting refractive surgery using an excimer laser, as it 
is also a limiting factor when planning for corneal 
refractive surgery (1-3). Its importance had been 
demonstrated by multiple studies that have provided 
evidence of the development of corneal ectasia among 
patients who have undergone refractive surgery (4-6). 
Although the minimum CCT that is appropriate for 
refractive procedures has been considered to be 500 µm 
(5), previous studies did not prove that refractive 
procedures on thinner corneas should be 
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contraindicated. Newer studies have provided evidence 
of the efficacy and safety of surface ablation in subjects 
with <500-µm-thick corneas, thereby opening up new 
horizons for the surgical treatment of these patients (7-
11). Due to the feasibility and potential cost-
effectiveness of photorefractive keratectomy (PRK), we 
aimed to evaluate its safety and efficacy for the 
treatment of patients with myopia and thin corneas who 
were followed up for a mean postoperative period of 4 
years. 
MATERIAL AND METHODS 
Study Design and Subjects 
This retrospective case series was approved by the ethics 
committee of the Baqiyatallah University of the Medical 
Sciences, Tehran, Iran. The study involved the evaluation 
of 4500 medical records in 2013 of patients who had 
been treated with PRK by two surgeons (MN and KhJ) 
from 2008 to 2010 at the Refractive Surgery Unit of 
Baqiyatallah Hospital, Tehran, Iran. We included subjects 
who had either simple or astigmatic myopia with CCT less 
than 500 µm based on Orbscan topography images and 
pachymetry using Tomey SP-3000 Pachymeter (Tomey 
Corp., Japan). 
However, we excluded the patients who had previous 
ocular surgery, suspected keratoconus (based on the 
Orbscan topography images), a coexisting ocular disease 
(such as cataracts and glaucoma), or a systemic disease 
(such as diabetic mellitus and connective tissue 
disorders). As documented in their medical records, after 
discussing the possible risks of the operation, informed 
consent to undergo the surgery was obtained from all 
the subjects. Based on the data in their medical records 
and the inclusion and exclusion criteria, we selected 110 
of the patients, and contacted them by telephone. Forty 
patients returned for follow-up assessment, but two 
were excluded due to the presence of cataracts. The 
remaining 38 patients signed informed consent forms to 
take part in the study. 
 
 
 
Assessments 
We recorded the subjects’ preoperative information 
including age, sex, refraction, CCT, and uncorrected and 
best-corrected visual acuity (UCVA and BCVA) measured 
by the LogMAR acuity testing chart, and we recorded the 
intraoperative ablation depth. We then conducted the 
following follow-up assessments of the subjects: 
refraction, CCT, UCVA, BCVA, Orbscan imaging, and a 
complete ophthalmic examination (including 
keratometry, fundoscopy, slit-lamp biomicroscopy, and 
tonometry). 
Surgical Technique 
The PRK was carried out by two surgeons (MN and KhJ). 
First, under sterile conditions and topical anesthesia 
(lidocaine 2%), the epithelium was loosened using a 17% 
alcohol solution for 15 seconds and manually removed 
using a blunt spatula. The optical zone diameter for all 
the subjects was 6 mm. Ablation was conducted using a 
Technolas 217P excimer laser (Technolas Perfect Vision 
GmbH, Munich, Germany) with a tissue-saving program. 
A sponge was soaked in mitomycin C (Kyowa Hakko 
Kogyo, Tokyo) 0.02% and applied to the ablated corneal 
stroma for a minimum of 10 seconds and a maximum of 
35 seconds (depending on the patient’s preoperative 
refraction), and then the area was vigorously irrigated 
with 20 ml cold balanced salt solution. Following the 
surgical procedure, a therapeutic soft contact lens Air 
Optix; Alcon Laboratories Inc, Fort Worth, Texas, USA) 
was laid on the eye, and topical antibiotic eyedrop 
Clobiotic 1%, (Sinadarou, Tehran, Iran) was administered. 
Postoperatively, the following medications were used: 
preservative-free artificial tears every 3 hours, Clobiotic 
1% eyedrop (Sinadarou, Tehran, Iran) every 4 hours, 
betamethasone 0.1% eyedrop (Sinadarou, Tehran, Iran) 
every 6 hours, and oral analgesic drugs. The patients 
were advised to avoid washing their face for 4 days. Once 
the epithelial damage healed, the betamethasone 0.1% 
eyedrop (Sinadarou, Tehran, Iran) was replaced with a 
fluorometholone eyedrop (Sinadarou, Tehran, Iran), and 
the dose was tapered off over 2 months. Refraction 
assessments were repeated 3 months postoperatively. 
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Statistical Analysis 
The collected data were entered into SPSS software 
(version 19; IBM Corp., Armonk, NY, USA). The data are 
presented as frequencies, percentages, means, standard 
deviations, and ranges, and, depending on the variable, 
one of the following statistical tests was applied: t-test, 
analysis of variance (ANOVA), or chi-square test. In 
addition, Pearson correlation coefficients were calculated 
to determine the correlation between postoperative 
myopia and preoperative myopia, age, CCT, and ablation 
depth, and between postoperative astigmatism and 
preoperative astigmatism and age. P < 0.05 was 
considered statistically significant 
RESULTS 
As shown in Table 1, the study included 74 eyes of 38 
patients with a mean age of 28.18 ± 6.82 years (range, 20 
– 46 years). Of the 74 eyes, 59 (79.7%) belonged to 30 
women, and 15 (20.3%) belonged to eight men. The 
mean follow-up period was 4 years (range, 3 – 5 years), 
with 23 (31.1%), 33 (44.6%), and 18 (24.30%), eyes being 
associated with follow-up periods of 3, 4, and 5 years, 
respectively. As shown in Table 2, the mean ± SD pre- 
and postoperative simple myopia was -2.77 ± 1.51 D 
(range, -0.75 – -8.00 D) and -0.24 ± 0.39 D (range, 0.00 – -
2.00 D), respectively. The mean ± SD pre- and 
postoperative astigmatic myopia was -0.82 ± 0.99 D (0.00 
– -5.50 D) and -0.37 ± 0.37 D (0.00 – -1.50 D), 
respectively. The mean ± SD pre- and postoperative CCT 
was 485.92 ± 9.27 µm (range, 446 – 498 µm) and 434.84 
± 20.48 µm (range, 385 – 477 µm), respectively. The 
mean ± SD pre- and postoperative BCVA and 
postoperative UCVA was 0.011 ± 0.03 (range 0.20 – 0.00), 
0.003 ± 0.01 (range, 0.10 – 0.00), and 0.054 ± 0.09 (0.40 – 
0.00), respectively. Of the 74 eyes assessed, the 
preoperative BCVA was 0.00 log MAR in 67 eyes (90.5%), 
0.10 log MAR in six eyes (8.10%), and 0.20 log MAR in 
one eye (1.4%); the postoperative BCVA was 0.00 log 
MAR in 72 eyes (97.3%) and 0.10 log MAR in two eyes 
(2.7%); and the postoperative UCVA was 0.00 log MAR in 
50 eyes (67.6%), 0.10 log MAR in 14 eyes (18.9%), 0.20 
log MAR in six eyes (8.1%), 0.3 log MAR in two eyes 
(2.7%), and 0.4 log MAR in two eyes (2.7%). The mean ± 
SD ablation depth was 54.34 ± 16.28 µm (range, 29–93 
µm). Regarding corneal clarity, 72 eyes (97.3%) had a 
clear cornea (grade 0) and two eyes of one patient 
(2.70%) had trace haze (grade 1). The safety index (i.e., 
the ratio of the mean postoperative BCVA to the mean 
preoperative BCVA) was 0.02 ± 0.12, and the efficacy 
index (i.e., the ratio of the mean postoperative UCVA to 
the mean preoperative BCVA) was 0.11 ± 0.50. 
 
Table 1. Baseline demographic variables 
Variable Value 
Sex  
Male 15 (20.3) 
Female 59 (79.7) 
Age 28.18 ± 6.82 
Range 20, 46 
SD: standard deviation 
Data are presented as No. (%) or Mean ± SD. 
 
 
 
Table 2. Pre- and postoperative ophthalmologic variables 
Variable Preoperative Postoperative 
 Mean ± SD Range Mean ± SD Range 
Myopia (D) -2.77 ± 1.51 0.00, -5.50 -0.24 ± 0.39 0.00, -2.00 
Astigmatism (D) -0.82 ± 0.99 -0.75, -8.00 -0.37 ± 0.37 0.00, -1.50 
CCT (µm) 485.92 ± 9.27 446, 498 434.84 ± 20.48 385, 477 
BCVA (logMAR) 0.011 ± 0.03 0.20, 0.00 0.003 ± 0.01 0.10, 0.00 
UCVA (logMAR) – – 0.054 ± 0.09 0.40, 0.00 
Myopia (D) -2.77 ± 1.51 0.00, -5.50 -0.24 ± 0.39 0.00, -2.00 
CCT: central corneal thickness; BCVA: best-corrected visual acuity; UCVA: uncorrected visual acuity; SD: standard deviation 
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The percentage of patients with preoperative myopia ≤ -
3.00 D, -3.1 to -6.00 D, and > -6.00 D was 75.70% (56 
eyes), 17.60% (13 eyes), and 6.8% (five eyes), 
respectively. The percentage of patients with 
postoperative myopia ≤ -0.50 D and > -0.50 D was 
89.10% (66 eyes) and 10.90% (eight eyes), respectively. 
Regarding changes in postoperative visual acuity, 91.90% 
(68 eyes) had no change and 8.10% (six eyes) had an 
improvement of one line on the Snellen chart. Of the six 
eyes with improved visual acuity, four had postoperative 
myopia ≤ -3.00 D, one had -3.01 to -6.00 D, and one had 
> -6.00 D, but the improvements in visual acuity were not 
significant (p > 0.05). Regarding CCT, 59.5% (44 eyes) had 
CCT > 430 µm, 35.1% (26 eyes) had CCT 400 – 430 µm, 
and 5.4% (four eyes) had CCT < 400 µm. None of the 
postoperative Orbscan topography images showed 
evidence of corneal ectasia. The Pearson correlation 
coefficient for age and preoperative myopia was weak 
and non-significant (0.035; P = 0.76). Regarding the 
correlations with postoperative myopia, for preoperative 
myopia, the Pearson correlation coefficient was strong 
and significant (0.7; P = 0.00), for ablation depth it was 
moderate and significant (0.46; P = 0.00), and for post-
operative CCT it was negative, moderate, and significant 
(-0.416; P = 0.00). Regarding the correlations with 
postoperative astigmatism, the Pearson correlation 
coefficient for age was negative, weak, and significant (-
0.315; P = 0.006) and for preoperative astigmatism, it 
was moderate and significant (0.45; P = 0.000). 
DISCUSSION 
This retrospective study showed that PRK was effective, 
safe, and predictable for the treatment of 74 eyes of 38 
myopic patients with <500-µm-thick corneas. There was 
no evidence of corneal ectasia in any of the subjects. At a 
mean of 4 years after PRK, 89.10% (66 eyes) had myopia 
≤ -0.50 D, which is a higher postoperative percentage 
than those reported in several previous PRK studies (12-
15). This could have occurred because our study had a 
shorter follow-up period compared to the previous 
studies or because of the intraoperative use of 
mitomycin C in our study. However, comparable studies 
that used a similar follow-up duration with or without 
the intraoperative use of mitomycin C can help for better 
clarification. 
A recent study by Hashemi et al (9) on the safety and 
efficacy of PRK in patients with myopia and thin corneas 
showed that the safety and efficacy indices were 1.01 ± 
0.05 and 1.00 ± 0.05, respectively. In addition, the 
refraction of all the subjects was within ± 0.50 D. In our 
study; we found that the safety index was 0.02 ± 0.12, 
the efficacy index was 0.11 ± 0.50, and 89.10% of the 
subjects had postoperative myopia ≤ -0.50 D. These 
differences could be due to the difference in the follow-
up period, as the study by Hashemi et al had a follow-up 
period of 1 year while ours had a mean follow-up period 
of 4 years. One of the limitations of our study is its 
retrospective nature, as 110 patients were asked to 
return for ocular examinations (at a mean of 4 years after 
surgery) and only 40 did so. However, the subjects who 
did not return for further evaluation may have declined 
to take part because they were satisfied with their 
postoperative UCVA. Another limitation of our study 
compared to the recently published studies in this field is 
the relatively short follow-up period, as it was much 
greater (i.e., 10 years) in several similar studies. 
However, other studies used a similar follow-up period or 
even shorter periods. Lastly, the lack of a control group 
of patients with myopia and normal CCT is another 
limitation of our study. In conclusion, regardless of its 
limitations, this study showed that PRK is safe and 
effective for treating patients with myopia and thin 
corneas. There was no risk of corneal ectasia at a mean 
of 4 years after surgery. Larger prospective studies with 
control groups may be necessary to confirm our findings. 
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